Life-threatening, delayed epistaxis after surgically assisted rapid palatal expansion: a case report
Abstract
Lutcavage GJ: Traumatic facial artery aneurysm and arteriovenous fistula: Case report. J Oral Maxillofac Surg 50:402, 1992 Wineland PL, Topazian RG, Marble HB Jr: False aneurysm of the facial artery. J Oral Surg 34:642, 1976 Akker HP van den, Lijn F van der: A false aneurysm of the facial artery as a complication of circumferential wiring. Oral Surg Oral Med Oral Path01 37:514,1974 Schwartz SH, Blankenship BJ, Stout RA: False aneurysm of the facial artery: Report of case. J Oral Surg 29:672,1971 Bresner M, Brekke J, Dubit J, et al: False aneurysm of the facial region. J Oral Surg 30:307, 1972 Cohen SM: Vascular surgery and reticuloendothelium system, in Rob C, Smith R (eds): Clinical Surgery, vol 14. Philadelphia, PA, Lippincott, 1967, pp 140-141 Schwartz HC, Kendrick RW, Pogrel BS: False aneurysm of the matiary artery: An unusual complication of closed facial trauma. Arch Otolaryngol109:616, 1983 Cohen MA: False (traumatic) aneurysm of the facial artery caused by a foreign body. Int J Oral Maxillofac Surg 15:336, 1986 Kennedy JW, Kent JN: False aneurysm and a partial facial paralysis secondary to mandibuiar fracture: Report of case. J Oral Surg 28:854, 1970 Taylor DV: Traumatic aneurysm and facial palsy as complication of a mandibular fracture. Br J Oral Surg 4:202, 1967 Calem WS: Traumatic (false) aneurysm of the terminal portion of the external carotid artery. Am J Surg 106:522, 1963 Wagner M: Pseudoaneurysm. A complication of percutaneous angiography and…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.